GlassScriptPhysician profile
Faisal W Chaudhry
NPI 1205829991
$737.23
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.21 · 2020: $148 · 2021: $92.67 · 2024: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $428.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $428.95 | 2024 | |
| Novo Nordisk INC | $92.71 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $51.32 | 2020 | |
| Allergan, INC. | $37.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.41 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $26.33 | 2021 | |
| Lilly USA, LLC | $18.43 | 2021 | |
| Strongbridge US INC. | $13.16 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.83 | 2019 | |
| Pfizer INC. | $12.48 | 2019 | |
| Ovik Health, LLC | $12.03 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.